Authors: Berry, SE Kinsella, TJ

Citation: Se. Berry et Tj. Kinsella, Targeting DNA mismatch repair for radiosensitization, SEM RAD ONC, 11(4), 2001, pp. 300-315

Authors: Yan, T Schupp, JE Hwang, HS Wagner, MW Berry, SE Strickfaden, S Veigl, ML Sedwick, WD Boothman, DA Kinsella, TJ

Citation: T. Yan et al., Loss of DNA mismatch repair imparts defective cdc2 signaling and G(2) arrest responses without altering survival after ionizing radiation, CANCER RES, 61(22), 2001, pp. 8290-8297

Authors: Kinsella, TJ Schupp, JE Davis, TW Berry, SE Hwang, HS Warren, K Balis, F Barnett, J Sands, H

Citation: Tj. Kinsella et al., Preclinical study of the systemic toxicity and pharmacokinetics of 5-iodo-2-deoxypyrimidinone-2 '-deoxyribose as a radiosensitizing prodrug in two, non-rodent animal species: Implications for phase I study design, CLIN CANC R, 6(9), 2000, pp. 3670-3679

Authors: Berry, SE Davis, TW Schupp, JE Hwang, HS de Wind, N Kinsella, TJ

Citation: Se. Berry et al., Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine, CANCER RES, 60(20), 2000, pp. 5773-5780

Authors: Berry, SE Garces, C Hwang, HS Kunugi, K Meyers, M Davis, TW Boothman, DA Kinsella, TJ

Citation: Se. Berry et al., The mismatch repair protein, hMLH1, mediates 5-substituted halogenated thymidine analogue cytotoxicity, DNA incorporation, and radiosensitization in human colon cancer cells, CANCER RES, 59(8), 1999, pp. 1840-1845